This is not the most recent version of the article. View current version (15 NOV 2013)

Intervention Review

Haloperidol versus placebo for schizophrenia

  1. Claire B Irving1,*,
  2. Clive E Adams1,
  3. Stephen Lawrie2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 18 OCT 2006

Assessed as up-to-date: 23 AUG 2006

DOI: 10.1002/14651858.CD003082.pub2


How to Cite

Irving CB, Adams CE, Lawrie S. Haloperidol versus placebo for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD003082. DOI: 10.1002/14651858.CD003082.pub2.

Author Information

  1. 1

    The University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

  2. 2

    University of Edinburgh, Department of Psychiatry, Edinburgh, Scotland, UK

*Claire B Irving, Cochrane Schizophrenia Group, The University of Nottingham, Institute of Mental Health, Sir Colin Campbell Building, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU, UK. Claire.Irving@nottingham.ac.uk. claireirving@btinternet.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 OCT 2006

SEARCH

This is not the most recent version of the article. View current version (15 NOV 2013)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stefan Leucht, Andrea Cipriani, Loukia Spineli, Dimitris Mavridis, Deniz Örey, Franziska Richter, Myrto Samara, Corrado Barbui, Rolf R Engel, John R Geddes, Werner Kissling, Marko Paul Stapf, Bettina Lässig, Georgia Salanti, John M Davis, Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis, The Lancet, 2013, 382, 9896, 951

    CrossRef

  2. 2
    Stefan Leucht, Jürgen Fritze, Mario Horst Lanczik, Roland Vauth, Hans Michael Olbrich, Psychische Erkrankungen, 2012,

    CrossRef

  3. 3
    Andrea G. Gillman, Joseph K. Leffel, Ann E.K. Kosobud, William Timberlake, Fentanyl, but not haloperidol, entrains persisting circadian activity episodes when administered at 24- and 31-h intervals, Behavioural Brain Research, 2009, 205, 1, 102

    CrossRef

  4. 4
    John Bola, Dennis Kao, Haluk Soydan, Clive E Adams, Antipsychotic medication for early episode schizophrenia, The Cochrane Library,
  5. 5
    Melanie J Powney, Clive E Adams, Hannah Jones, Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation), The Cochrane Library,
  6. 6
    Clive E Adams, Hanna Bergman, Claire B Irving, Stephen Lawrie, Haloperidol versus placebo for schizophrenia, The Cochrane Library,